Navigation Links
11th International Congress on Targeted Anticancer Therapies
Date:2/28/2013

Lugano/Amsterdam, 28 February 2013 -- A range of new and promising targeted drugs currently under development for improved cancer therapy will be presented during the 11th International Congress on Targeted Anticancer Therapies, Paris, 4-6 March 2013 (TAT 2013). The event, which is organised by NDDO Education Foundation, is an ESMO Partnership Meeting, co-sponsored by the U.S. National Cancer Institute.

Over 500 oncologists and scientists from all over the world will review and discuss cancer therapies of the future. Among them, many top academic experts involved in the early-phase clinical development of new targeted therapeutics and molecular cancer diagnostics, the cornerstones of personalised cancer therapy .

Personalised cancer medicine: targets and therapeutics

The development of new targeted cancer therapies is one of the main drivers for the further evolution of personalized cancer medicine. The concept of personalized medicine is based upon the notion that cancer development and progression are driven by genomic abnormalities and that these abnormalities are different not only between different types of cancer, but also between individual patients. Such findings have opened the door to the development of targeted cancer therapeutics, directed against tumour-specific molecular abnormalities.

At TAT 2013, over 50 plenary lectures and 70 posters will address dozens of emerging targeted agents and new drug targets under development for cancer therapy. In particular targets and experimental therapeutics in the early stages of clinical and the late stages of preclinical development will be addressed.

Program Highlights

  • Keynote Lecture "Targeting immune checkpoints in cancer therapy" (Michael B. Atkins, Washington, DC);
  • "New immune checkpoints as targets", featuring updates on four promising global drug development programmes targeting the immune system in cancer patients; '/>"/>

Contact: ESMO Press Office
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Ultracold matter technology from CU and SRI International licensed to Boulders ColdQuanta
2. International Polar Year conference: From knowledge to action
3. Large international study finds memory in adults impacted by versions of 4 genes
4. International team uncovers new genes that shape brain size, intelligence
5. Southampton researchers lead 2 international projects to help people out of poverty
6. UCSD researchers: Where international climate policy has failed, grassroots efforts can succeed
7. Washington University receives $8 million to lead international childhood malnutrition effort
8. Early Bird Discounts Available on International Healthcare and Biotechnology Conferences, Save Up To $600 with Global Information
9. New HealthFocus® International Study Reveals Five Very Different Weight Management Consumers
10. OU scientists and international team deciper the genetic code of the tomato
11. Digicel Launches Worlds First Biometric Identification System For International Money Transfers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... centres around a family of enzymes known as heme ... in their active site. At the centre of the ... oxidised (ferryl) when a reacting heme is in an ... remained unanswered for decades is whether this oxidation involves ... (OH). Resolving this fundamental question has implications for understanding ...
(Date:7/10/2014)... New research from The University of Texas Health Science ... it Real (IYG), a health education program designed to ... significantly reduce dating violence behaviors among minority youth. , ... 10 percent of high school youth are victims of ... than 20 percent are victims of emotional dating violence. ...
(Date:7/10/2014)... Spanish National Cancer Research Centre (CNIO) Macromolecular Crystallography ... a protein called BuD to DNA in order ... Montoya, the researcher who led the study, says ... edit the instructions contained in the genome to ... The study is published in the journal ...
Breaking Biology News(10 mins):Neutron crystallography solves long-standing biological mystery 2Neutron crystallography solves long-standing biological mystery 3It's Your Game ... Keep It Real reduces dating violence among minority youth 2CNIO scientists develop technology to redirect proteins towards specific areas of the genome 2
... sequenced an ancient RNA genome of a barley virus once ... back at least 2,000 years and revealing how intense farming at ... the University of Warwick have detected and sequenced the RNA genome ... found at a site near the River Nile in modern-day Egypt. ...
... Research UFZ present CLIMBER: Climatic niche characteristics ... on the climatic niche characteristics of 397 European butterflies ... provided in this dataset is of great relevance for ... high quality standards and open access, data ready to ...
... establish a state of the art Microbiorefinery (MBR) to ... Fossil fuel sources currently provide the basis for ... supplies and environmental considerations mean there is a growing ... The new facility, in collaboration with ...
Cached Biology News:RNA sequencing of 750-year-old barley virus sheds new light on the Crusades 2RNA sequencing of 750-year-old barley virus sheds new light on the Crusades 3Unique new dataset CLIMBER: Climatic niche characteristics of the butterflies in Europe 2University of Liverpool to establish microbiorefinery facility 2
(Date:1/15/2014)...   Niagara Thermal Products is proud to announce ... LLC ("B3") as the critical thermal component supplier in ... Army Corps of Engineers.  B3 has developed the only ... and destroys VOCs and other chemical pollutants, allergens and ...
(Date:1/15/2014)... 15, 2014 Cynvenio, a cancer diagnostics ... the genomic analysis of tumor cells in the bloodstream, ... web-based cancer decision support application powered by CollabRx, Inc. ... ClearID™ genomic test, Therapy Finder will provide breast cancer ...
(Date:1/15/2014)... Jan. 15, 2014 ­ RedBrick Health , a ... technology, today announces that EmblemHealth , the ... company, is now providing the RedBrick Compass health assessment, ... to all of its members. EmblemHealth is among the ...
(Date:1/15/2014)... A study has been launched to test whether technology ... help to tackle the problem of obesity.  This unique healthcare ... based in Stowmarket) and academics at University Campus Suffolk is ... which is inspired by equipment used to collect data about ...
Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
... February 26 Arpida Ltd.,(SWX: ARPN) today reported that ... intravenous iclaprim in its first indication,complicated Skin and Skin ... weeks., Arpida has agreed with the U.S. Food ... rolling process. Using a ,rolling NDA, allows modules,within the ...
... Therapeutics,Inc. (Nasdaq: TPTX ) today announced that ... TorreyPines, will present at Susquehanna,Financial Group,s Second Annual ... on Tuesday, March 4th at 11:00 a.m., Eastern., ... be available live. You can,access the webcast at: ...
... BURLINGTON, Mass., Feb. 26 Hyaluron ... development,services, continued to expand its business in ... and staffing increasing greater than 60 percent ... HCM acquired,additional space at its Burlington MA ...
Cached Biology Technology:Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim 2Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim 3TorreyPines Therapeutics to Present at Susquehanna Financial Group's Second Annual SIGnificant Options in Healthcare Conference 2HCM Announces Substantial Growth in 2007 2
... Degranulation, the secretion of cytoplasmic granules, ... inflammatory response of leukocytes (e.g. basophils, ... addition to histamine, these secretory granules ... cytokines, chemokines, and many proteases (Hallgren, ...
... Processing Service enables scientists who do not have ... software to have their biological samples tested for ... as easy as 1-2-3 Chose the ... samples from the S&S antibody menu. Send ...
... gel stain has bright fluorescence when bound to ... ideal for detecting dsDNA in gels using laser ... I nucleic gel acid stain has also ... and bandshift assays. One mL stains 100 minigels. ...
... techniques are defined by the author of ... This valuable hardcover guide includes hundreds of ... references. More than 300 pages detail the ... preparation from selection and design of ...
Biology Products: